Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Operating Expenses (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Operating Expenses for 15 consecutive years, with $16.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Expenses fell 14.99% year-over-year to $16.1 million, compared with a TTM value of $88.1 million through Sep 2025, up 18.67%, and an annual FY2024 reading of $85.2 million, up 38.95% over the prior year.
  • Operating Expenses was $16.1 million for Q3 2025 at Sanara MedTech, down from $23.9 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $24.4 million in Q4 2024 and bottomed at $5.6 million in Q1 2021.
  • Average Operating Expenses over 5 years is $15.2 million, with a median of $15.4 million recorded in 2023.
  • The sharpest move saw Operating Expenses surged 96.19% in 2022, then fell 14.99% in 2025.
  • Year by year, Operating Expenses stood at $9.7 million in 2021, then soared by 66.31% to $16.1 million in 2022, then grew by 0.36% to $16.1 million in 2023, then soared by 51.49% to $24.4 million in 2024, then plummeted by 34.23% to $16.1 million in 2025.
  • Business Quant data shows Operating Expenses for SMTI at $16.1 million in Q3 2025, $23.9 million in Q2 2025, and $23.7 million in Q1 2025.